SECTION 1: SOCIO-DEMOGRAPHIC DATA | ||||||
1 | SEX: M = Male, F = Female | |_| | ||||
2 | Age (in years) |
| ||||
3 | Marital status: S = single, M = married, D = Divorced | |_| | ||||
4 | Residence | |||||
5 | Region of origin: EN = Extreme North, N = North, A = Adamawa, C = Centre, W = west, NW = North west, SW = South west, E = East, L = Littoral | |_| | ||||
6 | Profession | |||||
SECTION 2: PAST MEDICAL AND FAMILY HISTORY | ||||||
7 | Chronic pathologies: Y = Yes, N = No | |_| | ||||
8 | If yes, what type; HTN, diabetes = D, Nephropathy = N, Endocrinopathy = Endoc to precise, Neoplasia = precise, Others (precise) | |_| | ||||
9 | Use of Medications Y = Yes, N = No | |_| | ||||
10 | Past surgery Y = Yes, N = No | |_| | ||||
11 | If yes, precise | |_| | ||||
12 | Smoking Active = A, passive = P, Non = N | |_| | ||||
13 | Alcohol comsuption Y = Yes, N = No | |_| | ||||
14 | If yes, IE = number × volume × % × alcohol density/day | |_| | ||||
15 | Sedentary life style Y = Yes, N = No | |_| | ||||
16 | Socio-professional stress Y = Yes, N = No | |_| | ||||
17 | Similar cas in family, Y = Yes, N = No | |_| | ||||
18 | Phaeochromocytoma, Y = Yes, N = No | |_| | ||||
19 | Thyroid medullary carcinoma, Y = Yes, N = No | |_| | ||||
20 | MEN type I Y = Yes, N = No | |_| | ||||
21 | Von Hipple—Lindau disease Y = Yes, N = No | |_| | ||||
22 | Neurofibromatosis Y = Yes, N = No | |_| | ||||
23 | Other tumor Y = Yes, N = No | |_| | ||||
24 | If yes precise | |_| | ||||
SECTION 3: CLINICAL EXAMINATION | ||||||
A-Functional Signs | ||||||
25 | Presenting complaint or circumstance of diagnosis | |||||
26 | Duration of evolution since presentation of first symptom |
| ||||
27 | Weight gain Yes |_|, No |_| | |_| | ||||
28 | Secondary ammenorrhoea Yes |_|, No |_| | |_| | ||||
29 | Decrease libido Yes |_|, No |_| | |_| | ||||
30 | Bone signs (non mechanical lumbar or pelvic pains) Yes |_|, No |_| | |_| | ||||
31 | Immunity disorders Yes |_|, No |_| | |_| | ||||
32 | Psychiatric disorders/problems Yes |_|, No |_| | |_| | ||||
33 | HTN Yes |_|, No |_| | |_| | ||||
34 | Neuromuscular signs Yes |_|, No |_| | |_| | ||||
35 | Constipation Yes |_|, No |_| | |_| | ||||
36 | PUPD syndrome Yes |_|, No |_| | |_| | ||||
37 | Cramps and paresthesia of extremeties Yes |_|, No |_| | |_| | ||||
38 | Dyspnea on effort Yes |_|, No |_| | |_| | ||||
39 | Intense pulsatile headache Yes |_|, No |_| | |_| | ||||
40 | Palpitations Yes |_|, No |_| | |_| | ||||
41 | Profuse sweating Yes |_|, No |_| | |_| | ||||
42 | Orthostatique hypotension | |_| | ||||
43 | Ascending constrictive pains:abdomen and thorax Yes |_|, No |_| | |_| | ||||
B-Physical Signs | ||||||
44 | General state: performance status index (WHO) | ……… | ||||
45 | Blood pressure | ……mm/Hg | ||||
46 | Pulse | ……….Bpm | ||||
47 | Respiratory rate | ………cpm | ||||
48 | Temperature | ……..˚C | ||||
49 | BMI: weight………(Kg)/Height…….(m) | |_| |_|kg/m2 | ||||
50 | Waist circumference | …..cm | ||||
51 | Facial and trunkal obesity Yes |_|, No |_| | |_| | ||||
52 | Easy bruising Yes |_|, No |_| | |_| | ||||
53 | Cutaneous eruptions (pupural at pertechies) Yes |_|, No |_| | |_| | ||||
54 | Signs of virilism Yes |_|, No |_| | |_| | ||||
55 | Amyotrophie of lower limbs Yes |_|, No |_| | |_| | ||||
56 | Pseudoparalytic crises Yes |_|, No |_| | |_| | ||||
57 | Cardiac arrhythmias Yes |_|, No |_| | |_| | ||||
58 | Gynaecomastia Yes |_|, No |_| | |_| | ||||
59 | Palpable tumour at the level of the abdomen | |_| | ||||
60 | Presence of goiter, exolpthalmos and signes of thyroid dysfunction Yes |_|, No |_| | |_| | ||||
61 | Gallactorrhoea Yes |_|, No |_| | |_| | ||||
62 | Presence of breast nodule Yes |_|, No |_| | |_| | ||||
63 | Peculiarities of rest of physical examination …………………………………………………………………………………… …………………………………………………………………………………… …………………………………………………………………………………… | |||||
SECTION 4: BIOLOGICAL INVESTIGATIONS | ||||||
Investigation | Results | Normal value | ||||
Aldosterone |
|
| ||||
Plasma renin activity |
|
| ||||
24 hrs CLU |
|
| ||||
Freinage minute test |
|
| ||||
● Midnight cortisol |
|
| ||||
● 8 h cortisol |
|
| ||||
ACTH |
|
| ||||
DHEAS |
|
| ||||
Testosterone |
|
| ||||
17OHP |
|
| ||||
Plasma metanephrines |
|
| ||||
24 hrs urinary metanephrines |
|
| ||||
Creatinnuria |
|
| ||||
Creatinine (mg/l) |
|
| ||||
Urea (g/l) |
|
| ||||
FBS |
|
| ||||
Na+/K+/Cl− (meq/l) |
|
| ||||
Ca2+/PO4/Mg2+ |
|
| ||||
Albuminemia (g/l) |
|
| ||||
EPPS |
|
| ||||
TSH (IU/l) |
|
| ||||
Free T4 pmol/L |
|
| ||||
CT/HDL/LDL/TG (g/l) |
|
| ||||
FBC, WBC |
|
| ||||
Hb |
|
| ||||
Platelets |
|
| ||||
CRP |
|
| ||||
ASAT/ALAT/GGT |
|
| ||||
Abdominal ultrasound………………………………………………………………………. ………………………………………………………………………………………………… ………………………………………………………………………………………………… Abdominal CT scan: ● Tumour location: left |_|, right |_| ● Size of tumour: ……….cm ● Content: homogenous |_|, heterogeneous|_| ● Spontaneous density: <10 HU |_|, >10 HU |_| ● Wash out: absolute……..%, Relative…………….% ● Limits: Regular irregular ● Necrosis: Yes |_|, No |_| ● Calcifications: Yes |_|, No |_| ● Infiltration of pararenal fats: Yes |_|, No |_| ● Hemorrhagic Yes |_|, No |_| ● Metastasis Yes |_|, No |_| Chest X-Ray:…………………………………………………………………………………. Others: ……………………………………………………………………………………….. | ||||||
SECTION 6: SURGICAL MANAGEMENT | ||||||
A-Pre-surgical preparation | ||||||
Pre-anesthetic consultation: ASA………………, Altemier | ||||||
Pre-surgical investigations: | ||||||
FBC, WBC | ||||||
Hb | ||||||
Platelets, TP TCK | ||||||
Urea creatinine | ||||||
64 | Multidispinary consertations (RCP) Yes |_|, No |_| |
| ||||
65 | Medications Yes |_|, No |_| |
| ||||
66 | If yes which type of medications? |
| ||||
67 | Blood transfusion Yes |_|, No |_| |
| ||||
B-Per operative | ||||||
Day of surgical intervention…………………………………………………… Duration with respect to onset of symptoms Type of Anesthesia:…………………………………………… Installation of patient:…………………………………………. | ||||||
68 | Indications: | |||||
69 | Type of surgical intervention: Laparoscopic open surgery | |||||
70 | Surgical technic: 1-Total adrenalectomy, 2-Partial adrenalectomy, | |||||
71 | Surgical approach: 1-anterior midline, 2-Anterior Subcostal, 3-Anterior bisubcostal 4-thoracoabdominal | |||||
72 | Surgical attitude: 1 = transperitoneal, 2 = extraperitoneal | |||||
73 | Intraoperative findings: | |||||
74 | Per-operative complications: HTN: Yes |_|, No |_| Hypotension Yes |_|, No |_| Bleeding Yes |_|, No |_| Cardiac arrest Yes |_|, No |_| Peritoneal breech Yes |_|, No |_| Pleural effraction Yes |_|, No |_| IVC injury Yes |_|, No |_| Adjacent organ injury Yes |_|, No |_| | |||||
75 | Duration of surgery: |
| ||||
76 | Specimen size………(cm) and weight……..(g) |
| ||||
C-Post surgery | ||||||
77 | Immediate ………………………………………………………………………………………… ………………………………………………………………………………………… | |||||
| ||||||
78 | Complications: Hemorrhage: Yes |_|, No |_| Anemia: Yes |_|, No |_| Surgical site infection: Yes |_|, No |_| | |||||
| Acute adrenal insufficiency: Yes |_|, No |_| Paralytic ileus: Yes |_|, No |_| Fistulas: Yes |_|, No |_| Death: Yes |_|, No |_| Others | |||||
79 | hospital stay duration |
| ||||
SECTION 7: DIAGNOSIS (Anatomopathological diagnosis) | ||||||
80 | Anatomopathological results:………………………………………………………… …………………………………………………………………………………………. | |||||
SECTION 8: ADJUVANT TREATMENT | ||||||
Hydrocortisone supplementation Yes |_|, No |_| Chemotherapy Yes |_|, No |_| | ||||||
SECTION 9: SURVEILLANCE | ||||||
81 | CLINICAL: Resolution of initial clinical signs Yes |_|, No |_| Appearance of new signs: Yes |_|, No |_| ………………………………………………………………. ………………………………………………………………………………………… Relapse | |||||
82 | Paraclinical: ● Cortisol 8 h ● Cortisol 1 H after synacthene test | Base 0 - 3 months 3 - 6 months >6 m | ||||
83 | Control abdominal CT scan |
| ||||